Hybrid Cardiac 68Ga-FAPI-4 PET/MRI in Dilated Cardiomyopathy: A Feasibility and Pilot Study.

Background Cardiac gallium 68-labeled fibroblast activation protein inhibitor (FAPI)-4 (68Ga-FAPI-4) PET/MRI allows simultaneous assessment of cardiac tissue characteristics, function, and molecular remodeling in myocardial diseases. An integrated workflow for nonischemic dila...

• Source: Radiology (RSNA) (PRIMARY)
• Type: Research

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.